How Long Do Most Seizures Last? A Systematic Comparison of Seizures Recorded in the Epilepsy Monitoring Unit

Purpose: More information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could influence seizure duration. Methods: Data were collected from a random sample of patients being evaluated with continuous video and scalp EE...

Full description

Saved in:
Bibliographic Details
Published inEpilepsia (Copenhagen) Vol. 47; no. 9; pp. 1499 - 1503
Main Authors Jenssen, Sigmund, Gracely, Edward J., Sperling, Michael R.
Format Journal Article
LanguageEnglish
Published Malden, USA Blackwell Publishing Inc 01.09.2006
Blackwell
Subjects
Online AccessGet full text
ISSN0013-9580
1528-1167
DOI10.1111/j.1528-1167.2006.00622.x

Cover

Abstract Purpose: More information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could influence seizure duration. Methods: Data were collected from a random sample of patients being evaluated with continuous video and scalp EEG. Seizure duration was defined as time from early sign of seizure (clinical or EEG) until the end of seizure on EEG. Seizures were categorized as simple partial (SPS), complex partial (CPS), secondarily generalized tonic–clonic (SGTCS), primary generalized tonic–clonic (PGTCS) and tonic (TS). SGTCS were divided into a complex partial part (SGTCS/CP) and a tonic–clonic part (SGTCS/TC). Median and longest duration of each seizure type in each individual were used. Comparisons of seizure types, first and last seizure, area of onset, and state of onset were performed. Results: Five hundred seventy‐nine seizures were recorded in 159 adult patients. Seizures with partial onset spreading to both hemispheres had the longest duration. SGTCS were unlikely to last more than 660 s, CPS more than 600 s, and SPS more than 240 s. PGTCS and TS had shorter durations, but the number of subjects with those two types was small. CPS did not differ in duration according to sleep state at onset nor side of origin. Conclusion: A working definition of status epilepticus in adults with cryptogenic or symptomatic epilepsy can be drawn from these data for purposes of future epidemiologic research. More information is needed for the idiopathic epilepsies and in children.
AbstractList Purpose: More information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could influence seizure duration. Methods: Data were collected from a random sample of patients being evaluated with continuous video and scalp EEG. Seizure duration was defined as time from early sign of seizure (clinical or EEG) until the end of seizure on EEG. Seizures were categorized as simple partial (SPS), complex partial (CPS), secondarily generalized tonic–clonic (SGTCS), primary generalized tonic–clonic (PGTCS) and tonic (TS). SGTCS were divided into a complex partial part (SGTCS/CP) and a tonic–clonic part (SGTCS/TC). Median and longest duration of each seizure type in each individual were used. Comparisons of seizure types, first and last seizure, area of onset, and state of onset were performed. Results: Five hundred seventy‐nine seizures were recorded in 159 adult patients. Seizures with partial onset spreading to both hemispheres had the longest duration. SGTCS were unlikely to last more than 660 s, CPS more than 600 s, and SPS more than 240 s. PGTCS and TS had shorter durations, but the number of subjects with those two types was small. CPS did not differ in duration according to sleep state at onset nor side of origin. Conclusion: A working definition of status epilepticus in adults with cryptogenic or symptomatic epilepsy can be drawn from these data for purposes of future epidemiologic research. More information is needed for the idiopathic epilepsies and in children.
Purpose: More information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could influence seizure duration. Methods: Data were collected from a random sample of patients being evaluated with continuous video and scalp EEG. Seizure duration was defined as time from early sign of seizure (clinical or EEG) until the end of seizure on EEG. Seizures were categorized as simple partial (SPS), complex partial (CPS), secondarily generalized tonic–clonic (SGTCS), primary generalized tonic–clonic (PGTCS) and tonic (TS). SGTCS were divided into a complex partial part (SGTCS/CP) and a tonic–clonic part (SGTCS/TC). Median and longest duration of each seizure type in each individual were used. Comparisons of seizure types, first and last seizure, area of onset, and state of onset were performed. Results: Five hundred seventy‐nine seizures were recorded in 159 adult patients. Seizures with partial onset spreading to both hemispheres had the longest duration. SGTCS were unlikely to last more than 660 s, CPS more than 600 s, and SPS more than 240 s. PGTCS and TS had shorter durations, but the number of subjects with those two types was small. CPS did not differ in duration according to sleep state at onset nor side of origin. Conclusion: A working definition of status epilepticus in adults with cryptogenic or symptomatic epilepsy can be drawn from these data for purposes of future epidemiologic research. More information is needed for the idiopathic epilepsies and in children.
Purpose: More information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could influence seizure duration. Methods: Data were collected from a random sample of patients being evaluated with continuous video and scalp EEG. Seizure duration was defined as time from early sign of seizure (clinical or EEG) until the end of seizure on EEG. Seizures were categorized as simple partial (SPS), complex partial (CPS), secondarily generalized tonic-clonic (SGTCS), primary generalized tonic-clonic (PGTCS) and tonic (TS). SGTCS were divided into a complex partial part (SGTCS-CP) and a tonic-clonic part (SGTCS-TC). Median and longest duration of each seizure type in each individual were used. Comparisons of seizure types, first and last seizure, area of onset, and state of onset were performed. Results: Five hundred seventy-nine seizures were recorded in 159 adult patients. Seizures with partial onset spreading to both hemispheres had the longest duration. SGTCS were unlikely to last more than 660 s, CPS more than 600 s, and SPS more than 240 s. PGTCS and TS had shorter durations, but the number of subjects with those two types was small. CPS did not differ in duration according to sleep state at onset nor side of origin. Conclusion: A working definition of status epilepticus in adults with cryptogenic or symptomatic epilepsy can be drawn from these data for purposes of future epidemiologic research. More information is needed for the idiopathic epilepsies and in children.
More information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could influence seizure duration. Data were collected from a random sample of patients being evaluated with continuous video and scalp EEG. Seizure duration was defined as time from early sign of seizure (clinical or EEG) until the end of seizure on EEG. Seizures were categorized as simple partial (SPS), complex partial (CPS), secondarily generalized tonic-clonic (SGTCS), primary generalized tonic-clonic (PGTCS) and tonic (TS). SGTCS were divided into a complex partial part (SGTCS/CP) and a tonic-clonic part (SGTCS/TC). Median and longest duration of each seizure type in each individual were used. Comparisons of seizure types, first and last seizure, area of onset, and state of onset were performed. Five hundred seventy-nine seizures were recorded in 159 adult patients. Seizures with partial onset spreading to both hemispheres had the longest duration. SGTCS were unlikely to last more than 660 s, CPS more than 600 s, and SPS more than 240 s. PGTCS and TS had shorter durations, but the number of subjects with those two types was small. CPS did not differ in duration according to sleep state at onset nor side of origin. A working definition of status epilepticus in adults with cryptogenic or symptomatic epilepsy can be drawn from these data for purposes of future epidemiologic research. More information is needed for the idiopathic epilepsies and in children.
More information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could influence seizure duration.PURPOSEMore information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could influence seizure duration.Data were collected from a random sample of patients being evaluated with continuous video and scalp EEG. Seizure duration was defined as time from early sign of seizure (clinical or EEG) until the end of seizure on EEG. Seizures were categorized as simple partial (SPS), complex partial (CPS), secondarily generalized tonic-clonic (SGTCS), primary generalized tonic-clonic (PGTCS) and tonic (TS). SGTCS were divided into a complex partial part (SGTCS/CP) and a tonic-clonic part (SGTCS/TC). Median and longest duration of each seizure type in each individual were used. Comparisons of seizure types, first and last seizure, area of onset, and state of onset were performed.METHODSData were collected from a random sample of patients being evaluated with continuous video and scalp EEG. Seizure duration was defined as time from early sign of seizure (clinical or EEG) until the end of seizure on EEG. Seizures were categorized as simple partial (SPS), complex partial (CPS), secondarily generalized tonic-clonic (SGTCS), primary generalized tonic-clonic (PGTCS) and tonic (TS). SGTCS were divided into a complex partial part (SGTCS/CP) and a tonic-clonic part (SGTCS/TC). Median and longest duration of each seizure type in each individual were used. Comparisons of seizure types, first and last seizure, area of onset, and state of onset were performed.Five hundred seventy-nine seizures were recorded in 159 adult patients. Seizures with partial onset spreading to both hemispheres had the longest duration. SGTCS were unlikely to last more than 660 s, CPS more than 600 s, and SPS more than 240 s. PGTCS and TS had shorter durations, but the number of subjects with those two types was small. CPS did not differ in duration according to sleep state at onset nor side of origin.RESULTSFive hundred seventy-nine seizures were recorded in 159 adult patients. Seizures with partial onset spreading to both hemispheres had the longest duration. SGTCS were unlikely to last more than 660 s, CPS more than 600 s, and SPS more than 240 s. PGTCS and TS had shorter durations, but the number of subjects with those two types was small. CPS did not differ in duration according to sleep state at onset nor side of origin.A working definition of status epilepticus in adults with cryptogenic or symptomatic epilepsy can be drawn from these data for purposes of future epidemiologic research. More information is needed for the idiopathic epilepsies and in children.CONCLUSIONA working definition of status epilepticus in adults with cryptogenic or symptomatic epilepsy can be drawn from these data for purposes of future epidemiologic research. More information is needed for the idiopathic epilepsies and in children.
Author Sperling, Michael R.
Jenssen, Sigmund
Gracely, Edward J.
Author_xml – sequence: 1
  givenname: Sigmund
  surname: Jenssen
  fullname: Jenssen, Sigmund
– sequence: 2
  givenname: Edward J.
  surname: Gracely
  fullname: Gracely, Edward J.
– sequence: 3
  givenname: Michael R.
  surname: Sperling
  fullname: Sperling, Michael R.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18185695$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/16981866$$D View this record in MEDLINE/PubMed
BookMark eNqNkV1rFDEUhoNU7Hb1L0hu9G7GfEwyCYhS1tUWVhRbr0M2k9EsM8k0ydKuv96su7bgTQ2EHDjPeQLnPQMnPngLAMSoxuW82dSYEVFhzNuaIMTrcgmp756A2X3jBMwQwrSSTKBTcJbSBiHU8pY-A6eYS4EF5zMwXIRbuAr-B_wQ4OeQMryy7tc22gRXOuX38Bxe7VK2o87OwEUYJx1dCh6G_oH8Zk2Ine2g8zD_tHA5ucFOaVeE3uUQXdF_L9Vz8LTXQ7Ivju8cXH9cXi8uqtWXT5eL81VlGklJpQlHa6rXgnEskGnbzuJ1b3vWlbZgjJCmaQjTXHLaMoJx1xjTSs4twlhqOgevD9ophputTVmNLhk7DNrbsE2KC8GplPhREEtGKeWkgC-P4HY92k5N0Y067tTfPRbg1RHQyeihj9oblx64QjFebHPw7sCZGFKKtlfG5bLa4HPUblAYqX3AaqP2Oap9jmofsPoTsLorAvGP4P6Px0ffHkZvSzq7_55Ty6-XpaC_AeJhupw
CODEN EPILAK
CitedBy_id crossref_primary_10_32708_uutfd_1441708
crossref_primary_10_1242_dmm_036194
crossref_primary_10_1212_WNL_0000000000200354
crossref_primary_10_1097_CCM_0b013e31828a3994
crossref_primary_10_1111_j_1528_1167_2007_01420_x
crossref_primary_10_1016_j_ncl_2021_08_001
crossref_primary_10_1016_j_nbd_2022_105637
crossref_primary_10_1016_j_pediatrneurol_2018_05_012
crossref_primary_10_1186_s43163_021_00114_9
crossref_primary_10_1017_S0317167100054093
crossref_primary_10_4065_84_6_495
crossref_primary_10_1111_epi_17089
crossref_primary_10_1111_j_1535_7511_2010_01368_x
crossref_primary_10_1016_j_cpem_2015_01_001
crossref_primary_10_3390_biomedicines10071491
crossref_primary_10_1016_j_seizure_2014_05_009
crossref_primary_10_1055_a_2180_7621
crossref_primary_10_1111_ane_12814
crossref_primary_10_1109_ACCESS_2019_2915609
crossref_primary_10_1097_ACO_0000000000000376
crossref_primary_10_1016_j_neuroscience_2007_05_047
crossref_primary_10_3389_fneur_2021_724904
crossref_primary_10_1111_epi_13291
crossref_primary_10_1016_j_clineuro_2014_02_023
crossref_primary_10_1055_a_2114_7954
crossref_primary_10_1111_epi_17756
crossref_primary_10_1002_acn3_50941
crossref_primary_10_1097_PEC_0000000000002745
crossref_primary_10_1111_j_1528_1167_2008_01669_x
crossref_primary_10_1016_j_yebeh_2020_107145
crossref_primary_10_1055_a_2029_4196
crossref_primary_10_1111_epi_14521
crossref_primary_10_14581_jer_11011
crossref_primary_10_1109_ACCESS_2018_2853125
crossref_primary_10_1056_NEJMcpc2027080
crossref_primary_10_1016_j_ncl_2023_04_001
crossref_primary_10_1016_j_nrl_2016_12_003
crossref_primary_10_1002_epd2_20243
crossref_primary_10_1016_j_seizure_2015_03_002
crossref_primary_10_1109_JIOT_2024_3395496
crossref_primary_10_5863_1551_6776_20_4_260
crossref_primary_10_1007_s12098_019_02946_z
crossref_primary_10_1002_epi4_12457
crossref_primary_10_1109_JBHI_2022_3208780
crossref_primary_10_1016_j_yebeh_2016_09_020
crossref_primary_10_1016_j_ccc_2012_11_007
crossref_primary_10_1016_j_yebeh_2012_07_014
crossref_primary_10_1016_j_yebeh_2021_108484
crossref_primary_10_1016_j_seizure_2021_06_011
crossref_primary_10_1016_j_yebeh_2011_03_035
crossref_primary_10_1007_s15202_013_0029_6
crossref_primary_10_1016_S1878_7762_10_70035_2
crossref_primary_10_1016_S1474_4422_15_00042_3
crossref_primary_10_1111_epi_13375
crossref_primary_10_1016_j_jneumeth_2020_108911
crossref_primary_10_1016_j_yebeh_2015_03_023
crossref_primary_10_1097_PCC_0000000000003338
crossref_primary_10_1016_j_seizure_2015_11_008
crossref_primary_10_1007_s00415_021_10925_8
crossref_primary_10_1016_j_seizure_2019_07_009
crossref_primary_10_1016_j_neuropharm_2015_11_001
crossref_primary_10_1016_j_neurot_2024_e00514
crossref_primary_10_1016_j_yebeh_2015_11_016
crossref_primary_10_1007_s15016_014_0518_7
crossref_primary_10_1097_WCO_0000000000000307
crossref_primary_10_1111_epi_13121
crossref_primary_10_1111_j_1468_1331_2009_02917_x
crossref_primary_10_12968_hmed_2013_74_1_18
crossref_primary_10_3390_e24111641
crossref_primary_10_1016_j_yebeh_2022_109072
crossref_primary_10_1024_1661_8157_a002596
crossref_primary_10_1142_S0129065723500120
crossref_primary_10_1016_j_clinph_2020_09_016
crossref_primary_10_1016_j_neuroimage_2015_02_059
crossref_primary_10_1016_j_seizure_2019_10_003
crossref_primary_10_1056_NEJMe1114206
crossref_primary_10_1055_a_2051_9291
crossref_primary_10_1002_epi4_12277
crossref_primary_10_1007_s11910_015_0594_5
crossref_primary_10_1002_epi4_12388
crossref_primary_10_1007_s00134_007_0915_5
crossref_primary_10_1016_j_ebr_2020_100409
crossref_primary_10_1016_j_yebeh_2014_05_018
crossref_primary_10_2460_javma_243_7_1001
crossref_primary_10_2217_ahe_09_91
crossref_primary_10_1016_j_bspc_2016_01_002
crossref_primary_10_1016_j_cnp_2016_09_002
crossref_primary_10_1016_j_eplepsyres_2011_05_018
crossref_primary_10_1016_j_pjnns_2018_04_002
crossref_primary_10_1016_j_ncl_2011_09_005
crossref_primary_10_52965_001c_56782
crossref_primary_10_1007_s11910_013_0357_0
crossref_primary_10_1111_epi_16577
crossref_primary_10_1517_14656566_2015_997212
crossref_primary_10_3389_fphar_2018_00193
crossref_primary_10_1016_j_sleep_2014_04_021
crossref_primary_10_1142_S0129065721500246
crossref_primary_10_1007_s15202_017_1498_9
crossref_primary_10_1016_j_nrleng_2018_11_004
crossref_primary_10_1186_s12883_022_02868_y
crossref_primary_10_1517_14656566_2016_1127354
crossref_primary_10_1038_s41598_022_25949_x
crossref_primary_10_1007_s12028_012_9695_z
crossref_primary_10_1016_j_neurol_2008_11_010
crossref_primary_10_1212_01_CON_0000284538_29811_da
crossref_primary_10_4103_jmss_jmss_138_21
crossref_primary_10_1371_journal_pcbi_1008689
crossref_primary_10_1080_02688697_2017_1324618
crossref_primary_10_1007_s00115_020_01036_2
crossref_primary_10_1097_AIA_0000000000000404
crossref_primary_10_3390_ijms23158191
crossref_primary_10_1152_jn_00721_2017
crossref_primary_10_1038_s41578_018_0062_3
crossref_primary_10_7759_cureus_48173
crossref_primary_10_1186_s12883_015_0486_y
crossref_primary_10_1016_j_pop_2024_02_008
crossref_primary_10_1016_j_brainres_2015_07_017
crossref_primary_10_1016_j_yebeh_2021_108312
crossref_primary_10_1016_S1634_7072_23_48698_9
crossref_primary_10_1017_S0790966700000306
crossref_primary_10_3389_fneur_2022_966480
crossref_primary_10_1109_JIOT_2021_3115505
crossref_primary_10_1111_ane_13356
crossref_primary_10_1038_s41420_023_01445_7
crossref_primary_10_1093_braincomms_fcac234
Cites_doi 10.1124/jpet.103.051920
10.1212/WNL.44.8.1403
10.1093/cercor/13.8.883
10.1016/S1388-2457(00)00543-5
10.1016/S0920-1211(02)00248-6
10.1016/j.eplepsyres.2003.10.009
10.1002/ana.410290524
10.1016/j.yebeh.2003.08.025
10.1002/ana.1018
10.1212/WNL.43.11.2280
10.1152/jn.1989.61.2.417
10.1523/JNEUROSCI.20-04-01290.2000
10.1093/brain/120.6.939
10.1046/j.1528-1157.2003.55502.x
10.1097/00124509-199903000-00003
10.1212/01.WNL.0000053748.83309.28
10.1097/00124509-200109000-00013
10.1002/ana.410440609
ContentType Journal Article
Copyright 2006 INIST-CNRS
Copyright_xml – notice: 2006 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7X8
DOI 10.1111/j.1528-1167.2006.00622.x
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList CrossRef

Neurosciences Abstracts
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1528-1167
EndPage 1503
ExternalDocumentID 16981866
18185695
10_1111_j_1528_1167_2006_00622_x
EPI622
Genre article
Journal Article
Comparative Study
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
24P
29G
2WC
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAGKA
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIVO
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHEFC
AI.
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FIJ
FUBAC
FYBCS
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IPNFZ
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OHT
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
TR2
UB1
V8K
V9Y
VH1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
YFH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
AAFWJ
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7X8
ID FETCH-LOGICAL-c4932-a260b3ab856180c77de1bfef5d4938552244425a696375211d4cc7966e0119a3
IEDL.DBID DR2
ISSN 0013-9580
IngestDate Fri Jul 11 01:52:09 EDT 2025
Fri Jul 11 00:34:57 EDT 2025
Wed Feb 19 01:43:25 EST 2025
Mon Jul 21 09:16:15 EDT 2025
Tue Jul 01 03:55:51 EDT 2025
Thu Apr 24 22:53:52 EDT 2025
Wed Jan 22 16:32:36 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Status epilepticus-Seizure duration- Seizure termination-Seizure classification. 0 1 |i
Nervous system diseases
Epilepsy
Central nervous system disease
Comparative study
Monitoring
Cerebral disorder
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4932-a260b3ab856180c77de1bfef5d4938552244425a696375211d4cc7966e0119a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
PMID 16981866
PQID 19533362
PQPubID 23462
PageCount 5
ParticipantIDs proquest_miscellaneous_68863991
proquest_miscellaneous_19533362
pubmed_primary_16981866
pascalfrancis_primary_18185695
crossref_citationtrail_10_1111_j_1528_1167_2006_00622_x
crossref_primary_10_1111_j_1528_1167_2006_00622_x
wiley_primary_10_1111_j_1528_1167_2006_00622_x_EPI622
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate September 2006
PublicationDateYYYYMMDD 2006-09-01
PublicationDate_xml – month: 09
  year: 2006
  text: September 2006
PublicationDecade 2000
PublicationPlace Malden, USA
PublicationPlace_xml – name: Malden, USA
– name: Malden, MA
– name: United States
PublicationTitle Epilepsia (Copenhagen)
PublicationTitleAlternate Epilepsia
PublicationYear 2006
Publisher Blackwell Publishing Inc
Blackwell
Publisher_xml – name: Blackwell Publishing Inc
– name: Blackwell
References 1991; 29
2001; 112
1989; 61
2003; 307
1997; 120
1993; 43
1999; 15
2000; 20
2003; 13
2003; 57
1994; 44
2003; 4
1972
2001; 49
2001; 17
2003; 60
1992; 33
2003; 53
1998; 44
2003; 44
e_1_2_5_14_2
e_1_2_5_13_2
e_1_2_5_9_2
e_1_2_5_8_2
e_1_2_5_15_2
e_1_2_5_7_2
e_1_2_5_10_2
e_1_2_5_6_2
e_1_2_5_5_2
e_1_2_5_12_2
e_1_2_5_20_2
e_1_2_5_4_2
e_1_2_5_11_2
e_1_2_5_21_2
e_1_2_5_3_2
e_1_2_5_2_2
e_1_2_5_18_2
e_1_2_5_17_2
Kramer R (e_1_2_5_16_2) 1992; 33
e_1_2_5_19_2
References_xml – volume: 20
  start-page: 1290
  year: 2000
  end-page: 6
  article-title: Activity‐dependent intracellular acidification correlates with the duration of seizure activity
  publication-title: J Neurosci
– volume: 15
  start-page: 5
  year: 1999
  end-page: 26
  article-title: The anticonvulsant hypothesis of the mechanisms of action of ECT: current status. [review][109 refs]
  publication-title: J ECT
– volume: 57
  start-page: 95
  year: 2003
  end-page: 109
  article-title: Reduction of intracellular calcium removal rate can explain changes in seizure dynamics: studies in neuronal network models
  publication-title: Epilepsy Res
– volume: 13
  start-page: 883
  year: 2003
  end-page: 93
  article-title: Partial cortical deafferentation promotes development of paroxysmal activity
  publication-title: Cereb Cortex
– volume: 43
  start-page: 2280
  year: 1993
  end-page: 4
  article-title: Carbamazepine withdrawal: effects of taper rate on seizure frequency
  publication-title: Neurology
– volume: 61
  start-page: 417
  year: 1989
  end-page: 26
  article-title: Evidence that repetitive seizures in the hippocampus cause a lasting reduction of GABAergic inhibition
  publication-title: J Neurophysiol
– volume: 307
  start-page: 129
  year: 2003
  end-page: 37
  article-title: The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy
  publication-title: J Pharmacol Exp Therap
– volume: 4
  start-page: 740
  year: 2003
  end-page: 5
  article-title: A retrospective analysis of the effects of magnet‐activated stimulation in conjunction with vagus nerve stimulation therapy
  publication-title: Epilepsy Behav
– start-page: 25
  year: 1972
  end-page: 90
– volume: 49
  start-page: 659
  year: 2001
  end-page: 64
  article-title: How long do new‐onset seizures in children last?
  publication-title: Ann Neurol
– volume: 53
  start-page: 65
  year: 2003
  end-page: 80
  article-title: External excitatory stimuli can terminate bursting in neural network models
  publication-title: Epilepsy Res
– volume: 29
  start-page: 575
  year: 1991
  article-title: Adenosine and seizure termination.[comment]
  publication-title: Ann Neurol
– volume: 44
  start-page: 908
  year: 1998
  end-page: 12
  article-title: Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus
  publication-title: Ann Neurol
– volume: 60
  start-page: 975
  year: 2003
  end-page: 8
  article-title: Occurrence of seizure clusters and status epilepticus during inpatient video‐EEG monitoring
  publication-title: Neurology
– volume: 17
  start-page: 210
  year: 2001
  end-page: 15
  article-title: ECT in the treatment of status epilepticus
  publication-title: J ECT
– volume: 44
  start-page: 752
  year: 2003
  end-page: 60
  article-title: Calorie restriction and ketogenic diet diminish neuronal excitability in rat dentate gyrus in vivo
  publication-title: Epilepsia
– volume: 44
  start-page: 1403
  year: 1994
  end-page: 7
  article-title: The secondarily generalized tonic‐clonic seizure: a videotape analysis. [see comment]
  publication-title: Neurology
– volume: 120
  start-page: 939
  year: 1997
  end-page: 53
  article-title: Ring chromosome 20 and nonconvulsive status epilepticus. A new epileptic syndrome. [review][38 refs]
  publication-title: Brain
– volume: 112
  start-page: 241
  year: 2001
  end-page: 9
  article-title: Epileptic seizures are characterized by changing signal complexity
  publication-title: Clin Neurophysiol
– volume: 33
  issue: suppl 3
  year: 1992
  article-title: The duration of secondarily generalized tonic‐clonic seizures
  publication-title: Epilepsia
– volume: 33
  issue: 3
  year: 1992
  ident: e_1_2_5_16_2
  article-title: The duration of secondarily generalized tonic‐clonic seizures
  publication-title: Epilepsia
– ident: e_1_2_5_7_2
  doi: 10.1124/jpet.103.051920
– ident: e_1_2_5_15_2
  doi: 10.1212/WNL.44.8.1403
– ident: e_1_2_5_3_2
  doi: 10.1093/cercor/13.8.883
– ident: e_1_2_5_2_2
  doi: 10.1016/S1388-2457(00)00543-5
– ident: e_1_2_5_11_2
  doi: 10.1016/S0920-1211(02)00248-6
– ident: e_1_2_5_8_2
  doi: 10.1016/j.eplepsyres.2003.10.009
– ident: e_1_2_5_5_2
  doi: 10.1002/ana.410290524
– ident: e_1_2_5_13_2
  doi: 10.1016/j.yebeh.2003.08.025
– ident: e_1_2_5_18_2
  doi: 10.1002/ana.1018
– ident: e_1_2_5_20_2
  doi: 10.1212/WNL.43.11.2280
– ident: e_1_2_5_4_2
  doi: 10.1152/jn.1989.61.2.417
– ident: e_1_2_5_6_2
  doi: 10.1523/JNEUROSCI.20-04-01290.2000
– ident: e_1_2_5_17_2
– ident: e_1_2_5_14_2
  doi: 10.1093/brain/120.6.939
– ident: e_1_2_5_9_2
  doi: 10.1046/j.1528-1157.2003.55502.x
– ident: e_1_2_5_10_2
  doi: 10.1097/00124509-199903000-00003
– ident: e_1_2_5_19_2
  doi: 10.1212/01.WNL.0000053748.83309.28
– ident: e_1_2_5_12_2
  doi: 10.1097/00124509-200109000-00013
– ident: e_1_2_5_21_2
  doi: 10.1002/ana.410440609
SSID ssj0007673
Score 2.287187
Snippet Purpose: More information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could...
Purpose: More information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could...
More information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1499
SubjectTerms Adult
Anticonvulsants. Antiepileptics. Antiparkinson agents
Biological and medical sciences
Cerebral Cortex - physiopathology
Electroencephalography - methods
Electroencephalography - statistics & numerical data
Epilepsy - classification
Epilepsy - diagnosis
Epilepsy - physiopathology
Functional Laterality - physiology
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
Humans
Investigative techniques, diagnostic techniques (general aspects)
Medical sciences
Monitoring, Physiologic - methods
Monitoring, Physiologic - statistics & numerical data
Nervous system
Nervous system (semeiology, syndromes)
Neurology
Neuropharmacology
Pharmacology. Drug treatments
Radionuclide investigations
Sampling Studies
Seizure classification
Seizure duration
Seizure termination
Status epilepticus
Status Epilepticus - diagnosis
Status Epilepticus - physiopathology
Terminology as Topic
Time Factors
Videotape Recording
Title How Long Do Most Seizures Last? A Systematic Comparison of Seizures Recorded in the Epilepsy Monitoring Unit
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1528-1167.2006.00622.x
https://www.ncbi.nlm.nih.gov/pubmed/16981866
https://www.proquest.com/docview/19533362
https://www.proquest.com/docview/68863991
Volume 47
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEB5CDiVQ0kfS1H1sdcjVS2zZsnUqIdmwabMh5AG5GcmSy5JgL7WXtvn1nbG8u3VJIITcDHogyTPSN5rRNwC7hZShFqhplp7nRkLkvgwT43Odp9wahCCaHjhPTsX4Kvp2HV938U_0FsbxQywv3Egz2v2aFFzpuq_kcYgWUCCShU9BhOGQ8GTABdHoH56vmKQS0TmbA-7LON3rB_Xc21HvpHo5UzUuWuGyXdwHR_votj2ejl7BzWJiLirlZjhv9DC_-4_z8Xlm_ho2OxTL9p3YvYE1W76FF5POT78Ft-PqFzupyh_ssGKTqm7YhZ3ezdG0Zyeqbr6yfXaxpJBmB8tciKwqVjWdZWwNm5YMYSobzXC0s_oPc_sQXUgygszbcHk0ujwY-11eBz-PEC76Cm0ozZVOEbule3mSGBvowhaxweI0RkQYRbiVKIGbQ4LwIjBRnidol1kiqFP8HayXVWnfA-OWSjiCoAKhhtFaGml5WihtiBhNepAsfmGWd5znlHrjNvvH9sG1zGgtKSMnxfjhWma_PQiWLWeO9-MRbQY9KVk1JFQkZOzBl4XYZKjF5JpRpa3mdUbOTI5Y4uEaIk0JTAYe7Dh5W_UuZEtb6EHcSs2jx5uNzo7x48MT232EDXcfRQF3n2C9-Tm3nxGhNXqAunf8fdBq4F-9wCp0
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrZ3fS9xAEMeHotAWRPvTRlvdh77mMNlkk30S0ZNT76TUK_gWstlNEY_kMDmq_vXOZHN3jShI6Vsg2ZBsZjaf2dn9DsD3XEpfCfQ0Q9tzAyEyV_qRdrnKYm40IoiiDc6jczH4FZxehpdtOSDaC2P1IRYTbuQZzXhNDk4T0l0vD30MgTwRzZMKwvd7CJSrTbqOCOnnUksqEm262eOuDOO97rKeJ-_U-VetTdMKuy239S6eAtIu3zY_qOMNmMxfza5Lue7NatXL7h-pPv6nd38H6y3IsgNree_hlSk-wOtRm6r_CJNB-YcNy-I3OyrZqKxqdmGu7mcY3bNhWtX77IBdLFSk2eGiHCIr8-WVNjg2ml0VDEmV9af4uNPqjtmhiOYkGVHzJxgf98eHA7ct7eBmARKjm2IYpXiqYsS3eC-LIm08lZs81Hg6DhEKgwBHk1Tg-BAhYXg6yLIIQzNDGnUp_wwrRVmYL8C4oTMcOShH2tBKSS0Nj_NUadJGkw5E82-YZK3sOVXfmCR_hT_Ylwn1JRXlpGV-2JfJrQPeouXUSn-8oM1Ox0yWDQmMhAwd2J3bTYKOTNmZtDDlrEoon8kRJ56_QsQx8aTnwKY1uOXdhWyUCx0IG7N58fMm_R8neLD1j-124c1gPBomw5Pzs214a6enaP3dV1ipb2bmGwJbrXYaR3wAarktmQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dS9xAEB-KBSlIP6y2qVb3oa85TDbZZJ-KeHec9U6kKvgWstmNiJKEJofWv74z2dxdUyxI6VtgP5LdzOz-Zmf2NwBfcil9JVDTDF3PDYTIXOlH2uUqi7nRCEEUXXCenYrJZfDtKrzq4p_oLozlh1geuJFmtOs1KXil876Shz5aQJ6IFj4F4fsDxJMvA3w5hXcNv6-opCLReZs97sowPuhH9TzZU2-r2qjSGmctt-kunsKjfXjb7k_jN3C7GJkNS7kdzBs1yB7_IH38P0N_C687GMsOrdy9gxem2IT1Weeofw93k_KeTcvimg1LNivrhp2bm8c52vZsmtbNV3bIzpcc0uxomQyRlfmqpjWNjWY3BUOcykYVfm1V_2R2IaITSUaYeQsuxqOLo4nbJXZwswDxopuiEaV4qmIEb_FBFkXaeCo3eaixOA4REgYBriWpwNUhQnzh6SDLIjTMDDHUpXwb1oqyMB-BcUMlHFFQjlhDKyW1NDzOU6WJGU06EC1-YZJ1pOeUe-Mu-c34wblMaC4pJScF-eFcJg8OeMuWlSX-eEabvZ6UrBoSLBIydGB_ITYJqjH5ZtLClPM6IW8mRzDx9xoijglNeg58sPK26l3IlrfQgbCVmmd_bzI6O8aHT__Ybh_Wz4bjZHp8erIDr-zZFAXf7cJa82NuPiNaa9Req4a_AKThLEg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=How+Long+Do+Most+Seizures+Last%3F+A+Systematic+Comparison+of+Seizures+Recorded+in+the+Epilepsy+Monitoring+Unit&rft.jtitle=Epilepsia+%28Copenhagen%29&rft.au=Jenssen%2C+Sigmund&rft.au=Gracely%2C+Edward+J.&rft.au=Sperling%2C+Michael+R.&rft.date=2006-09-01&rft.issn=0013-9580&rft.eissn=1528-1167&rft.volume=47&rft.issue=9&rft.spage=1499&rft.epage=1503&rft_id=info:doi/10.1111%2Fj.1528-1167.2006.00622.x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_j_1528_1167_2006_00622_x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0013-9580&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0013-9580&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0013-9580&client=summon